HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AKESO

90.300

-3.300-3.53%

Volume:8.94M

Turnover:814.22M

Market Cap:83.17B

PE:-62.67

High:92.700

Open:92.450

Low:90.250

Close:93.600

52wk High:156.000

52wk Low:80.200

Shares:921.00M

HK Float Shares:921.00M

Volume Ratio:0.79

T/O Rate:0.97%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.441

ROE:-13.59%

ROA:-4.57%

PB:8.38

PE(LYR):-62.67

PS:20.62

Loading ...

Overview Company News Filings

Stock Track | Akeso Plummets 5.07% Intraday on Disappointing Ivonescimab Phase III Interim Results

Phase Ii Data From a Randomized Double-Blind Trial of Ligufalimab (Anti-Cd47) Combination Therapy in Frontline Aml Published at Eha 2026

THOMSON REUTERS

AKESO Maintains Stable Capital Structure in April; Issued Shares Steady at 921.14 Million

Bulletin Express

Stock Track | AKESO Soars 5.32% in Morning Session as Market Reassesses Ivonescimab Trial Interim Results

AKESO Shares Climb Over 5% in Morning Session as Institutions Remain Confident in Ivonescimab's Potential Against Keytruda

Stock Track | Akeso Plummets 9.65% Intraday After Partner's Clinical Trial Disappointment

3 Asian Stocks Estimated To Be Up To 31.8% Below Intrinsic Value

Simply Wall St.

AKESO（09926）2025年总收入达305.62亿元分（30.562亿元），双特异抗体商业化与研发并进，净亏损有所扩大

Bulletin Express

Akeso reminds non-registered shareholders of switch to electronic corporate communications

Bulletin Express

Akeso publishes 2025 ESG report

Akeso says Phase III HARMONi-2 trial shows ivonescimab beats pembrolizumab on PFS

AKESO's Cadonilimab Demonstrates Counter-Seasonal Quarterly Growth, Says Bank of America

Stock Track | AKESO Soars 5.24% Intraday on Positive Phase II Pancreatic Cancer Trial Data

Akeso (SEHK:9926) Valuation Check After Positive Cadonilimab Phase II Data In Advanced Pancreatic Cancer

Simply Wall St.

BUZZ-HK-listed Akeso slides to 3-week low

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress

Stock Track | AKESO Plummets 5.69% Intraday as Fundamental Concerns Overshadow Positive Clinical Data

Is It Too Late To Consider Akeso (SEHK:9926) After Strong Five Year Share Gains?

Simply Wall St.

AKESO Shares Climb Nearly 3% on Positive Phase II Data for Cadonilimab Combo in Pancreatic Cancer

Akeso says cadonilimab-chemo extends OS past 23 months in phase 2 pancreatic cancer trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/09926/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"AKESO","latestPrice":90.3,"timestamp":1789110505718,"preClose":93.6,"halted":0,"volume":8940530,"delay":0,"changeRate":-0.03525641025641023,"floatShares":921000000,"shares":921000000,"eps":-1.4408075107197191,"marketStatus":"Trading","change":-3.3,"latestTime":"09-11 15:08:27","open":92.45,"high":92.7,"low":90.25,"amount":814224209,"amplitude":0.026175,"askPrice":90.35,"askSize":23000,"bidPrice":90.3,"bidSize":24000,"shortable":3,"etf":0,"ttmEps":-1.235930568780289,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":2,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":93.6,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":0.790635,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"AKS.HK","impliedVol":0.6952,"impliedVolPercentile":0.7},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":921000000,"roa":"-4.57%","roe":"-13.59%","lyrEps":-1.440808,"volumeRatio":0.790635,"shares":921000000,"dividePrice":0,"high":92.7,"amplitude":0.026175,"preClose":93.6,"low":90.25,"week52Low":80.2,"pbRate":"8.38","psRate":"20.62","week52High":156,"institutionHeld":0,"latestPrice":90.3,"committee":0.021277,"eps":-1.4408075107197191,"divideRate":0,"volume":8940530,"delay":0,"ttmEps":-1.235930568780289,"open":92.45,"prevYearClose":113,"prevWeekClose":101.2,"prevMonthClose":89.9,"prevQuarterClose":88.05,"fiveDayClose":101.2,"twentyDayClose":96,"sixtyDayClose":83.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-26","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"Post-Mkt","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.56,"hold":0.04,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.56,"analysts":25,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2026-09-10","current":-73.062357,"percent":0.276284,"low":-283.614883,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"high":20.221708,"avg":-48.562811,"sd":59.136963,"marketCap":86219001273},"quantilePoints":[{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-05-02","current":-143.58439,"twenty":-55.295104,"median":-23.989446,"eighty":13.587555,"marketCap":78807100452},{"date":"2025-05-09","current":-136.980788,"twenty":-56.345373,"median":-23.982021,"eighty":13.592632,"marketCap":75710466095},{"date":"2025-05-16","current":-134.501562,"twenty":-57.376977,"median":-23.982021,"eighty":13.592632,"marketCap":74947527196},{"date":"2025-05-23","current":-133.538341,"twenty":-57.747713,"median":-23.982021,"eighty":13.592632,"marketCap":74633375884},{"date":"2025-05-30","current":-133.993142,"twenty":-58.91872,"median":-23.982021,"eighty":13.592632,"marketCap":75216799748},{"date":"2025-06-06","current":-131.180073,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"marketCap":73825558226},{"date":"2025-06-13","current":-152.810216,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":86032580619},{"date":"2025-06-20","current":-145.842175,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":81948613568},{"date":"2025-06-27","current":-147.346424,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":83025703780},{"date":"2025-07-04","current":-184.930979,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":104208477933},{"date":"2025-07-11","current":-180.493504,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":101605509923},{"date":"2025-07-18","current":-224.51725,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":126288827263},{"date":"2025-07-25","current":-237.059172,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":133828458741},{"date":"2025-08-01","current":-250.051759,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":140291000008},{"date":"2025-08-08","current":-255.97072,"twenty":-59.773257,"median":-23.989446,"eighty":13.587555,"marketCap":143971058230},{"date":"2025-08-15","current":-264.505775,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":148548691628},{"date":"2025-08-22","current":-283.614883,"twenty":-59.98102,"median":-23.989446,"eighty":13.587555,"marketCap":158781048634},{"date":"2025-08-29","current":-151.096607,"twenty":-60.061292,"median":-23.989446,"eighty":13.587555,"marketCap":139755257503},{"date":"2025-09-05","current":-154.217836,"twenty":-62.354796,"median":-23.989446,"eighty":13.587555,"marketCap":142500849327},{"date":"2025-09-12","current":-134.834957,"twenty":-64.590671,"median":-23.989446,"eighty":13.587555,"marketCap":124814900348},{"date":"2025-09-19","current":-129.155078,"twenty":-65.225568,"median":-24.062263,"eighty":13.587555,"marketCap":119472269927},{"date":"2025-09-26","current":-132.486221,"twenty":-66.989962,"median":-24.124656,"eighty":13.587555,"marketCap":122235699455},{"date":"2025-10-03","current":-139.242464,"twenty":-67.293654,"median":-24.261227,"eighty":13.582478,"marketCap":128775816004},{"date":"2025-10-10","current":-127.67557,"twenty":-67.910041,"median":-24.342298,"eighty":13.587555,"marketCap":117906326528},{"date":"2025-10-17","current":-122.384529,"twenty":-68.235995,"median":-24.417444,"eighty":13.587555,"marketCap":112932153377},{"date":"2025-10-24","current":-114.955731,"twenty":-68.842466,"median":-24.58122,"eighty":13.587555,"marketCap":106115693875},{"date":"2025-10-31","current":-112.991017,"twenty":-69.234459,"median":-24.630996,"eighty":13.587555,"marketCap":104457636158},{"date":"2025-11-07","current":-111.865223,"twenty":-69.783847,"median":-24.772153,"eighty":13.587555,"marketCap":103352264347},{"date":"2025-11-14","current":-118.110846,"twenty":-71.021734,"median":-24.903626,"eighty":13.587555,"marketCap":109431809308},{"date":"2025-11-21","current":-106.428879,"twenty":-71.496538,"median":-25.008455,"eighty":13.587555,"marketCap":98562319832},{"date":"2025-11-28","current":-121.801586,"twenty":-72.238759,"median":-25.173816,"eighty":13.587555,"marketCap":113208496330},{"date":"2025-12-05","current":-122.779771,"twenty":-72.794834,"median":-25.300444,"eighty":13.587555,"marketCap":114313868141},{"date":"2025-12-12","current":-122.948103,"twenty":-73.382927,"median":-25.403597,"eighty":13.587555,"marketCap":114682325412},{"date":"2025-12-19","current":-115.46697,"twenty":-74.211201,"median":-25.633881,"eighty":13.587555,"marketCap":107957980227},{"date":"2025-12-24","current":-110.590517,"twenty":-74.659967,"median":-25.640942,"eighty":13.587555,"marketCap":103720721617},{"date":"2026-01-02","current":-110.841788,"twenty":-75.482016,"median":-25.637411,"eighty":13.592632,"marketCap":104365521840},{"date":"2026-01-09","current":-124.521475,"twenty":-75.983701,"median":-25.679301,"eighty":13.547374,"marketCap":117537869257},{"date":"2026-01-16","current":-117.698232,"twenty":-76.738768,"median":-25.679301,"eighty":13.547374,"marketCap":111458324296},{"date":"2026-01-23","current":-113.429847,"twenty":-77.350039,"median":-25.679301,"eighty":13.547374,"marketCap":107313180004},{"date":"2026-01-30","current":-107.001444,"twenty":-78.004549,"median":-25.679301,"eighty":13.547374,"marketCap":101694206630},{"date":"2026-02-06","current":-97.546473,"twenty":-79.287468,"median":-25.773598,"eighty":13.494628,"marketCap":92943346458},{"date":"2026-02-13","current":-101.218847,"twenty":-80.266586,"median":-25.825195,"eighty":13.494537,"marketCap":96996376432},{"date":"2026-02-20","current":-105.022841,"twenty":-80.777808,"median":-25.722001,"eighty":13.494719,"marketCap":100496720501},{"date":"2026-02-27","current":-101.788736,"twenty":-81.405078,"median":-25.722001,"eighty":13.494719,"marketCap":98470205514},{"date":"2026-03-06","current":-102.999959,"twenty":-82.133452,"median":-25.722001,"eighty":13.494719,"marketCap":98838662784},{"date":"2026-03-13","current":-105.298763,"twenty":-83.363188,"median":-25.722001,"eighty":13.494719,"marketCap":101509977995},{"date":"2026-03-20","current":-110.878439,"twenty":-84.977693,"median":-25.773598,"eighty":13.494628,"marketCap":106484151145},{"date":"2026-03-27","current":-92.387071,"twenty":-90.917747,"median":-25.773598,"eighty":13.494628,"marketCap":116432497446},{"date":"2026-04-02","current":-102.201748,"twenty":-96.788708,"median":-25.773598,"eighty":13.494628,"marketCap":129420616228},{"date":"2026-04-10","current":-99.759281,"twenty":-97.56233,"median":-25.773598,"eighty":13.494628,"marketCap":127301986923},{"date":"2026-04-17","current":-108.953175,"twenty":-98.069701,"median":-25.773598,"eighty":13.494628,"marketCap":139092619576},{"date":"2026-04-24","current":-94.949835,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":121222441961},{"date":"2026-04-30","current":-97.955024,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":125091243300},{"date":"2026-05-08","current":-96.322328,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":123433185584},{"date":"2026-05-15","current":-86.175907,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":110721409755},{"date":"2026-05-22","current":-83.786417,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":107405294321},{"date":"2026-05-29","current":-84.570211,"twenty":-99.339337,"median":-25.773598,"eighty":13.494628,"marketCap":108787009085},{"date":"2026-06-05","current":-66.928875,"twenty":-99.331319,"median":-25.825195,"eighty":13.494537,"marketCap":86219001273},{"date":"2026-06-12","current":-65.829318,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":84745172192},{"date":"2026-06-18","current":-62.495243,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":80646085058},{"date":"2026-06-26","current":-59.753298,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":76731226560},{"date":"2026-07-03","current":-73.399324,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":94325061222},{"date":"2026-07-10","current":-69.793507,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":89581173866},{"date":"2026-07-17","current":-63.181388,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":81382999599},{"date":"2026-07-24","current":-71.139059,"twenty":-99.315284,"median":-25.984476,"eighty":13.494356,"marketCap":91653746012},{"date":"2026-07-31","current":-67.043638,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":86541401385},{"date":"2026-08-07","current":-71.222684,"twenty":-99.323302,"median":-25.904836,"eighty":13.494447,"marketCap":92114317600},{"date":"2026-08-14","current":-68.287327,"twenty":-99.323302,"median":-26.043394,"eighty":13.494447,"marketCap":88429744896},{"date":"2026-08-21","current":-64.055639,"twenty":-99.315284,"median":-26.109825,"eighty":13.494356,"marketCap":83133171634},{"date":"2026-08-28","current":-77.864086,"twenty":-99.292622,"median":-26.202149,"eighty":13.326528,"marketCap":87831001831},{"date":"2026-09-04","current":-82.608113,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":93219689411},{"date":"2026-09-10","current":-76.301372,"twenty":-99.277979,"median":-26.442363,"eighty":13.158791,"marketCap":86219001273}],"updateTime":1789110507920},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125138786","title":"Stock Track | Akeso Plummets 5.07% Intraday on Disappointing Ivonescimab Phase III Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1125138786","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125138786?lang=en_us&edition=fundamental","pubTime":"2026-05-18 10:57","pubTimestamp":1779073043,"startTime":"0","endTime":"0","summary":"Akeso's stock plummeted 5.07% during intraday trading, extending recent declines for the biopharmaceutical company.The sharp drop follows market digestion of disappointing interim results from the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635494709","title":"Phase Ii Data From a Randomized Double-Blind Trial of Ligufalimab (Anti-Cd47) Combination Therapy in Frontline Aml Published at Eha 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635494709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635494709?lang=en_us&edition=fundamental","pubTime":"2026-05-15 15:44","pubTimestamp":1778831053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA93SMFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720050803.USD","BK1574","LU0348784397.USD","LU2488822045.USD","LU0348767384.USD","LU2778985437.USD","LU0348827113.USD","LU0540923850.HKD","LU2399975544.HKD","LU2476274308.USD","LU0348825331.USD","LU2476274720.SGD","BK1161","LU0417516571.SGD","09926","LU0561508036.HKD","IE00B543WZ88.USD","LU0348783233.USD","LU0417516902.SGD","LU0634319403.HKD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","IE00BPRC5H50.USD","LU0348766576.USD","LU1794554557.SGD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104056034","title":"AKESO Maintains Stable Capital Structure in April; Issued Shares Steady at 921.14 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1104056034","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104056034?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:23","pubTimestamp":1778055785,"startTime":"0","endTime":"0","summary":"Akeso, Inc. reported no changes to its share capital during April 2026, keeping both authorised and issued share counts intact. The company’s authorised share capital remained at 5.00 billion...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129022352","title":"Stock Track | AKESO Soars 5.32% in Morning Session as Market Reassesses Ivonescimab Trial Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1129022352","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129022352?lang=en_us&edition=fundamental","pubTime":"2026-05-06 10:49","pubTimestamp":1778035771,"startTime":"0","endTime":"0","summary":"AKESO's stock price surged 5.32% during the morning trading session, marking a significant rebound for the biopharmaceutical company.The upward movement represents a recovery following a previous...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190831371","title":"AKESO Shares Climb Over 5% in Morning Session as Institutions Remain Confident in Ivonescimab's Potential Against Keytruda","url":"https://stock-news.laohu8.com/highlight/detail?id=1190831371","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190831371?lang=en_us&edition=fundamental","pubTime":"2026-05-06 09:55","pubTimestamp":1778032516,"startTime":"0","endTime":"0","summary":"AKESO (09926) saw its shares rise more than 5% during the morning trading session. At the time of writing, the stock was up 5.48%, trading at HK$134.8 with a turnover of HK$555 million. On the news...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU1035773651.USD","SG9999001176.USD","LU0234572021.USD","LU1974910355.USD","LU1291159041.SGD","LU1069347547.HKD","LU0965509010.AUD","IE00B543WZ88.USD","LU0942090050.USD","LU0648001328.SGD","LU0203345920.USD","BK4516","LU1023059063.AUD","SG9999014542.SGD","LU2488822045.USD","LU1699723380.USD","BK4533","LU0348767384.USD","LU1116320901.HKD","SG9999014567.USD","BK1574","LU1037948541.HKD","LU0561508036.HKD","LU1934455194.USD","LU2023250504.SGD","LU2023250843.SGD","LU0965508806.USD","LU2361044949.HKD","LU0265550359.USD","LU0266013472.USD","LU0289739699.SGD","SG9999014559.SGD","LU0634319403.HKD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0098860793.USD","LU0130517989.USD","LU1057294990.SGD","LU0965509283.SGD","BK4534","LU0348784397.USD","LU0208291251.USD","LU1066051225.USD","LU1061106388.HKD","LU1201861249.SGD","BK4559","LU1983299246.USD","LU1430594728.SGD","LU1162221912.USD","LU0965509101.SGD","BK1161","LU0477156953.USD","LU0432979614.USD","IE000M9KFDE8.USD","LU1929549753.HKD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2476274720.SGD","LU0861579265.USD","LU0348766576.USD","LU0058720904.USD","LU1934455277.USD","BK4588","LU0320765646.SGD","LU0985320562.USD","LU1720050803.USD","LU0348783233.USD","LU1961090484.USD","LU2357627491.SGD","LU0540923850.HKD","LU2112291526.USD","LU1116320737.USD","SG9999014575.USD","IE00BPRC5H50.USD","LU1794554557.SGD","LU2125154778.USD","LU1934455863.HKD","SG9999002232.USD","LU1093756325.SGD","LU0348735423.USD","LU0006306889.USD","LU2106854487.HKD","BK4550","IE00BFTCPJ56.SGD","LU2360032135.SGD","LU1066051498.USD","LU1037948897.HKD","LU1066053197.SGD","LU1989771016.USD","IE00BLSP4239.USD","LU2468319806.SGD","LU0868494617.USD","IE0002141913.USD","IE00BSNM7G36.USD","LU0130102774.USD","SG9999002224.SGD","BK4007","LU2361045086.USD","LU0238689110.USD","LU2399975544.HKD","LU2491049909.HKD","LU1571399168.USD","LU1941712264.USD","LU1066051811.HKD","LU1941712348.USD","SG9999015358.SGD","LU2089984988.USD","LU0980610538.SGD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BLSP4452.SGD","LU0211331839.USD","09926","SG9999001176.SGD","LU1989772923.USD","LU1093756168.USD","LU1585245621.USD","LU2361044865.SGD","LU0417516571.SGD","SG9999015341.SGD","IE0009355771.USD","IE00BN8TJ469.HKD","IE00B5MMRT66.SGD","IE00B2B36J28.USD","LU0348827113.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1989772840.SGD","LU0203347892.USD","LU2461242641.AUD","IE00BBT3K403.USD","LU2476274308.USD","LU0106261372.USD","LU2125154935.USD","BK4585","LU2491050154.USD","LU1917777945.USD","LU0320765489.SGD","LU0417516902.SGD","LU0122379950.USD","LU0868494708.USD","LU0265550946.USD","SG9999013999.USD","LU0070302665.USD","LU2778985437.USD","LU0859254822.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104766980","title":"Stock Track | Akeso Plummets 9.65% Intraday After Partner's Clinical Trial Disappointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1104766980","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104766980?lang=en_us&edition=fundamental","pubTime":"2026-05-04 09:38","pubTimestamp":1777858720,"startTime":"0","endTime":"0","summary":"Akeso's stock plummeted 9.65% during intraday trading on Monday, following negative news regarding a key clinical trial for a co-developed drug.The decline came after Akeso's overseas partner, Summit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632696357","title":"3 Asian Stocks Estimated To Be Up To 31.8% Below Intrinsic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2632696357","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632696357?lang=en_us&edition=fundamental","pubTime":"2026-05-01 06:04","pubTimestamp":1777586671,"startTime":"0","endTime":"0","summary":"As global markets navigate geopolitical tensions and economic uncertainties, Asian equities have shown resilience, with some indices maintaining stability amid fluctuating conditions. In this environment, identifying undervalued stocks can offer opportunities for investors seeking to capitalize on potential market inefficiencies. Recognizing a good stock often involves assessing its intrinsic value relative to its current price, especially in regions like Asia where emerging economic trends...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9612017-choice2-main-header/1585186662059","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612017-choice2-main-header/1585186662059"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/tw/tech/twse-2383/elite-material-shares/news/3-asian-stocks-estimated-to-be-up-to-318-below-intrinsic-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/tw/tech/twse-2383/elite-material-shares/news/3-asian-stocks-estimated-to-be-up-to-318-below-intrinsic-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","LU0417516738.SGD","LU1720050803.USD","LU2476274308.USD","LU0348784397.USD","LU1794554557.SGD","LU0348827113.USD","LU0348783233.USD","LU0348767384.USD","LU0348825331.USD","LU0561508036.HKD","LU1961090484.USD","IE00BPRC5H50.USD","LU2488822045.USD","LU0634319403.HKD","LU0417516571.SGD","09926","LU2476274720.SGD","BK1161","LU2778985437.USD","LU0540923850.HKD","LU0348766576.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0417516902.SGD","LU2399975544.HKD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106640568","title":"AKESO（09926）2025年总收入达305.62亿元分（30.562亿元），双特异抗体商业化与研发并进，净亏损有所扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1106640568","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106640568?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:30","pubTimestamp":1777476651,"startTime":"0","endTime":"0","summary":"根据AKESO（股票代码：09926）最新年度报告，2025年公司总收入达到人民币30.562亿元（即人民币3,056.2百万除以100得到30.562亿元），较2024年的21.239亿元（即人民币2,123.9百万除以100得到21.239亿元）同比增长43.9%。其中商业销售收入（扣除分销费用后）约为30.331亿元（3,033.1百万÷100），同比上升51.48%；许可收入为0.232亿...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AKESO（09926）2025年总收入达305.62亿元分（30.562亿元），双特异抗体商业化与研发并进，净亏损有所扩大","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122936220","title":"Akeso reminds non-registered shareholders of switch to electronic corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1122936220","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122936220?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:25","pubTimestamp":1777476336,"startTime":"0","endTime":"0","summary":"Akeso, Inc. issued a reminder on 29 April 2026 that it has fully adopted electronic dissemination for all future corporate communications—including annual and interim reports, meeting notices,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631569545","title":"Akeso publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631569545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631569545?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:51","pubTimestamp":1777474304,"startTime":"0","endTime":"0","summary":"Akeso outlined 2025 ESG priorities after identifying 21 material issues, including clinical trial safety, product quality, data security, R&D innovation, business ethics.Anti-corruption and compliance training covered 3,752 employees with 99.8% participation; director participation was 66.7%.Company reported no corruption-related lawsuits or legal disputes settled or accepted during 2025.Akeso reported 1,085 cumulative patent applications with 218 granted; trademark applications totaled 534 with 434 registered.Supply chain controls included 41 on-site supplier audits with 97.56% pass rate; supplier base totaled 469 in China, 47 outside China.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akeso Inc. published the original content used ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL873qM1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348767384.USD","LU2476274308.USD","LU2778985437.USD","LU0348735423.USD","LU0561508036.HKD","LU1961090484.USD","LU2399975544.HKD","LU1794554557.SGD","LU0417516902.SGD","LU0348827113.USD","LU2476274720.SGD","09926","LU0348766576.USD","LU1720050803.USD","LU2488822045.USD","LU0348783233.USD","LU0348784397.USD","LU0540923850.HKD","IE00B5MMRT66.SGD","BK1574","BK1161","LU0348825331.USD","IE00BPRC5H50.USD","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630373008","title":"Akeso says Phase III HARMONi-2 trial shows ivonescimab beats pembrolizumab on PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2630373008","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630373008?lang=en_us&edition=fundamental","pubTime":"2026-04-28 16:08","pubTimestamp":1777363732,"startTime":"0","endTime":"0","summary":"Akeso reported April 28, 2026 that ivonescimab gained upgraded recommendations in 2026 CSCO guideline for non-small cell lung cancer, strengthening its positioning in first-line treatment.Phase III HARMONi-2 results were already presented in guideline update, supporting ivonescimab monotherapy as preferred option versus pembrolizumab in PD-L1-positive disease.Phase III HARMONi-6 results were cited as positive, supporting ivonescimab with chemotherapy in first-line squamous disease, with regulatory review ongoing for this use.Guideline update also maintained ivonescimab with chemotherapy as recommended option for EGFR-mutant disease following resistance, supporting broader commercial reach across treatment lines.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3DXs5f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0634319403.HKD","LU0348825331.USD","09926","LU1794554557.SGD","IE00BPRC5H50.USD","LU0417516902.SGD","LU0561508036.HKD","LU0417516738.SGD","LU2778985437.USD","IE00B5MMRT66.SGD","LU2399975544.HKD","LU1961090484.USD","BK1574","LU2476274720.SGD","LU0348767384.USD","LU0348766576.USD","LU0417516571.SGD","LU0348735423.USD","LU0348783233.USD","LU2476274308.USD","LU1720050803.USD","LU0348827113.USD","IE00B543WZ88.USD","LU2488822045.USD","LU0540923850.HKD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185557523","title":"AKESO's Cadonilimab Demonstrates Counter-Seasonal Quarterly Growth, Says Bank of America","url":"https://stock-news.laohu8.com/highlight/detail?id=1185557523","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185557523?lang=en_us&edition=fundamental","pubTime":"2026-04-28 15:08","pubTimestamp":1777360098,"startTime":"0","endTime":"0","summary":"Bank of America Securities has released a research report indicating that AKESO's (09926) cadonilimab achieved quarter-over-quarter growth against seasonal trends. In February, the sample drug sales...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU0348827113.USD","LU0348783233.USD","LU0540923850.HKD","LU1720050803.USD","LU0348766576.USD","09926","IE00BPRC5H50.USD","LU0348735423.USD","LU2476274308.USD","LU0634319403.HKD","LU1794554557.SGD","161027","LU0561508036.HKD","IE00B543WZ88.USD","LU1961090484.USD","BK1574","LU0417516902.SGD","LU2488822045.USD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU0348825331.USD","LU2399975544.HKD","BK1161","LU2778985437.USD","LU0417516571.SGD","LU0417516738.SGD","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125463972","title":"Stock Track | AKESO Soars 5.24% Intraday on Positive Phase II Pancreatic Cancer Trial Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1125463972","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125463972?lang=en_us&edition=fundamental","pubTime":"2026-04-27 13:03","pubTimestamp":1777266211,"startTime":"0","endTime":"0","summary":"AKESO's stock surged 5.24% during intraday trading on Monday, marking a significant upward movement for the biopharmaceutical company.The sharp rise appears driven by continued positive investor...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630800051","title":"Akeso (SEHK:9926) Valuation Check After Positive Cadonilimab Phase II Data In Advanced Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2630800051","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630800051?lang=en_us&edition=fundamental","pubTime":"2026-04-26 06:09","pubTimestamp":1777154986,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after presenting positive Phase II COMPASSION-26 data at the 2026 AACR meeting, highlighting cadonilimab plus chemotherapy in advanced pancreatic ductal adenocarcinoma.\nSee our latest analysis for Akeso.\nAkeso's share price is trading at HK$131.6 after a 16.15% year-to-date share price return, with recent clinical updates arriving alongside a 12.96% 90-day share price gain and a very large 3-year total shareholder return of 207.12%. This suggests momentum...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-valuation-check-after-positive-cadonilimab-ph","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-valuation-check-after-positive-cadonilimab-ph","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348827113.USD","09926","LU0348735423.USD","LU2476274720.SGD","LU0348784397.USD","LU2488822045.USD","IE0031619046.USD","LU0348825331.USD","LU1815336091.USD","LU1961090484.USD","BK1574","LU0417516738.SGD","LU0561508036.HKD","LU1720050803.USD","BK4157","AEIS","IE00B7SZL793.SGD","LU0348783233.USD","LU2399975544.HKD","LU0757428866.USD","IE00B66KJ199.SGD","BK1161","LU0540923850.HKD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0348767384.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","LU0348766576.USD","LU1794554557.SGD","IE00B19Z4B17.USD","LU2476274308.USD","LU0417516571.SGD","LU2778985437.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883254","title":"BUZZ-HK-listed Akeso slides to 3-week low","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629883254?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:50","pubTimestamp":1776930641,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Akeso slides to 3-week low** Shares of antibody drugs developer Akeso Inc 9926.HK plunge 12.9% to HK$130, their lowest level since March 31** Stock on track for the biggest one-day pct decline since April 7, 2025; top pct loser in Hang Seng Biotech Index .HSBIO, which is down 4.1% ** Stock up nearly 15% in the last three weeks** \"Think it should be profit taking after Akeso confirmed LBA  in ASCO ,\" said Cui Cui, head of Asia Healthcare at Jefferies ** Onshore investors had been betting on positive data since early March, and the LBA suggests potentially positive results but inline with market expectations, Cui says** Nomura keeps \"neutral\" rating and lifts target price to HK$142.75 from HK$112.73, saying Akeso's ivonescimab is set to report overall survival  data from HARMONi-6 trial at ASCO annual meeting from May 29 to June 2 ** \"The results should be good,\" Nomura wrote, adding the LBA in the plenary-session status suggests that the OS data is most likely to be posit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL1N4160BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU0417516738.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","BK1161","LU0348766576.USD","LU0348825331.USD","LU2399975544.HKD","LU2778985437.USD","LU1961090484.USD","LU1720050803.USD","LU0348783233.USD","LU0417516902.SGD","LU0634319403.HKD","LU2476274720.SGD","LU2488822045.USD","LU1794554557.SGD","LU0540923850.HKD","LU2476274308.USD","LU0348827113.USD","LU0417516571.SGD","LU0348784397.USD","09926","IE00BPRC5H50.USD","LU0561508036.HKD","LU0348767384.USD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165196464","title":"HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165196464","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165196464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:32","pubTimestamp":1776915127,"startTime":"0","endTime":"0","summary":"HK biotech stocks fell. Akeso down 12%; Remegen, Zai Lab, KeyMed and Junshi down 7%; Lepu and Innocare down 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","02162","06606","09606","09995","06978","02269","02137","02359","09926","03347","01672","09966","09688","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184360495","title":"Stock Track | AKESO Plummets 5.69% Intraday as Fundamental Concerns Overshadow Positive Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1184360495","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184360495?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:40","pubTimestamp":1776908440,"startTime":"0","endTime":"0","summary":"AKESO's stock plummeted 5.69% during intraday trading, giving back gains from the previous session.The sharp decline comes despite the recent release of positive Phase II clinical data for its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629146045","title":"Is It Too Late To Consider Akeso (SEHK:9926) After Strong Five Year Share Gains?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629146045","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629146045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:20","pubTimestamp":1776856803,"startTime":"0","endTime":"0","summary":"If you are wondering whether Akeso shares still offer value after a strong run, the numbers behind the current price deserve a closer look.\nAt a last close of HK$149.30, Akeso has delivered returns of 1.3% over 7 days, 33.2% over 30 days, 31.8% year to date and 60.7% over 1 year, with a very large 3 year gain and 173.2% over 5 years.\nThese moves have put Akeso on the radar of investors trying to understand what is already priced in and what may still be up for grabs. Recent coverage has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/is-it-too-late-to-consider-akeso-sehk9926-after-strong-five","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/is-it-too-late-to-consider-akeso-sehk9926-after-strong-five","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1961090484.USD","LU0417516738.SGD","LU0561508036.HKD","BK1574","IE00BPRC5H50.USD","LU2488822045.USD","LU0348825331.USD","LU0348784397.USD","LU0348827113.USD","LU0417516571.SGD","LU0417516902.SGD","09926","LU2778985437.USD","LU2476274308.USD","LU1720050803.USD","LU0634319403.HKD","LU0348783233.USD","LU0348766576.USD","LU2399975544.HKD","LU0348735423.USD","LU1794554557.SGD","IE00B543WZ88.USD","BK1161","LU2476274720.SGD","LU0540923850.HKD","LU0348767384.USD","IE00B5MMRT66.SGD","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101728190","title":"AKESO Shares Climb Nearly 3% on Positive Phase II Data for Cadonilimab Combo in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1101728190","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101728190?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:36","pubTimestamp":1776825408,"startTime":"0","endTime":"0","summary":"AKESO (09926) saw its shares rise by nearly 3%. As of the time of writing, the stock was up 2.66%, trading at HK$150.6 with a turnover of HK$613 million. The increase follows the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","LU0348783233.USD","LU0417516902.SGD","LU0561508036.HKD","LU0417516571.SGD","BK1161","LU2476274720.SGD","09926","BK1574","BK4588","IE00B5MMRT66.SGD","LU0348766576.USD","LU1794554557.SGD","LU0634319403.HKD","LU2488822045.USD","LU0348767384.USD","LU0417516738.SGD","BK4585","LU2778985437.USD","LU0348735423.USD","LU1961090484.USD","IE00BPRC5H50.USD","LU0348827113.USD","LU1720050803.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU2476274308.USD","LU0348825331.USD","VXUS","LU0348784397.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629706348","title":"Akeso says cadonilimab-chemo extends OS past 23 months in phase 2 pancreatic cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629706348","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629706348?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:54","pubTimestamp":1776740090,"startTime":"0","endTime":"0","summary":"Akeso reported Phase II COMPASSION-26 results for cadonilimab with chemotherapy in first-line advanced pancreatic cancer, already presented at AACR 2026.Data showed improved survival outcomes, with strongest benefit in locally advanced disease.Study also indicated broad tumor control across overall population, with similar response patterns in locally advanced and metastatic patients.Safety profile remained manageable, with no new safety concerns flagged.Update reinforces Akeso strategy to expand cadonilimab use into hard-to-treat tumors, supporting its longer-term growth outlook in oncology immunotherapy.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL62fwjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0561508036.HKD","LU0348784397.USD","BK1574","LU2476274720.SGD","LU0348767384.USD","LU0417516738.SGD","LU1720050803.USD","LU0348766576.USD","LU0540923850.HKD","BK1161","LU2476274308.USD","IE00BPRC5H50.USD","LU2778985437.USD","LU0417516902.SGD","LU2488822045.USD","09926","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1794554557.SGD","LU0348735423.USD","LU1961090484.USD","LU2399975544.HKD","LU0348825331.USD","LU0348827113.USD","LU0348783233.USD","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}